Literature DB >> 10507533

Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex.

X D Wang1, X Q Chen, H H Yang, G Y Hu.   

Abstract

Huperzine A, a selective inhibitor of acetylcholinesterase, was recently demonstrated to exert an antagonist effect on N-methyl-D-aspartate (NMDA) receptor in rat cerebral cortex. In the present study, the effects of six cholinesterase inhibitors, e.g. huperzine A, huperzine B, tacrine, donepezil (E2020), physostigmine and galanthamine on [3H]dizocilpine (MK-801) binding to synaptic membrane of rat cerebral cortex were compared. Their IC50 values (mean +/- SD) were 36.9 +/- 12.1, 316.8 +/- 93.2, 33.2 +/- 3.7, 135.0 +/- 15.1, 50.4 +/- 7.4, and 3344 +/- 295 microM, respectively. The rank order of potency is tacrine approximately huperzine A > physostigmine > donepezil > huperzine B >> galanthamine. There is no correlation between their activities to inhibit [3H]MK-801 binding and to inhibit acetylcholinesterase (r = +0.563, P = 0.245). The results suggest that most cholinesterase inhibitors available exhibit an antagonist effect on NMDA receptor in rat cerebral cortex in addition to their inhibitory effect on acetylcholinesterase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507533     DOI: 10.1016/s0304-3940(99)00567-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia.

Authors:  Ying Wang; Lu-qi Huang; Xi-can Tang; Hai-yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

2.  Hypobaric Preconditioning Modifies Group I mGluRs Signaling in Brain Cortex.

Authors:  Dmitry G Semenov; Alexandr V Belyakov; Tatjana S Glushchenko; Mikhail O Samoilov; Elzbieta Salinska; Jerzy W Lazarewicz
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

3.  Potassium channel modulation by acetylcholinesterase inhibitor donepezil.

Authors:  E I Solntseva; J V Bukanova; V G Skrebitsky
Journal:  Dokl Biol Sci       Date:  2005 Nov-Dec

4.  Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.

Authors:  Juan Jose Ramos-Rodriguez; Mar Pacheco-Herrero; Diana Thyssen; Maria Isabel Murillo-Carretero; Esther Berrocoso; Tara L Spires-Jones; Brian J Bacskai; Monica Garcia-Alloza
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

5.  MK801- and scopolamine-induced amnesias are reversed by an Amazonian herbal locally used as a "brain tonic".

Authors:  Adriana Lourenço da Silva; Bárbara da Silva Martins; Viviane de Moura Linck; Ana Paula Herrmann; Nathalia Mai; Domingos S Nunes; Elaine Elisabetsky
Journal:  Psychopharmacology (Berl)       Date:  2008-08-10       Impact factor: 4.530

6.  Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease.

Authors:  Debby Van Dam; Katrien Coen; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2007-11-16       Impact factor: 4.530

7.  Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.

Authors:  Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Elżbieta Salińska; Lidia Strużyńska
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

8.  Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms.

Authors:  David Tweedie; Koji Fukui; Yazhou Li; Qian-Sheng Yu; Shani Barak; Ian A Tamargo; Vardit Rubovitch; Harold W Holloway; Elin Lehrmann; William H Wood; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Henriette Van Praag; Yu Luo; Barry J Hoffer; Robert E Becker; Chaim G Pick; Nigel H Greig
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.